Kevin M. Koo

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics

• Broschiertes Buch

Produktbeschreibung

This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.

Produktdetails

• Springer Theses
• Verlag: Springer / Springer International Publishing / Springer, Berlin
• Artikelnr. des Verlages: 978-3-030-31002-8
• 1st ed. 2019
• Seitenzahl: 116
• Erscheinungstermin: 7. Oktober 2020
• Englisch
• Abmessung: 235mm x 155mm x 7mm
• Gewicht: 189g
• ISBN-13: 9783030310028
• ISBN-10: 3030310027
• Artikelnr.: 60161440

Inhaltsangabe

Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management.- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout.- Label -Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets.- Amplification-Free Electrochemical RNA Biomarker Sensing.- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.